Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma

Ophthalmic Plastic and Reconstructive Surgery

Volumn 22, Issue 2, 2006, Pages 113-115

  Shepler, Todd R ^a,b   Prieto, Victor G ^a   Diba, Roxana ^a   Neuhaus, Russell W ^b   Shore, John W ^b   Esmaeli, Bita ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Texas Oculoplastic Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; EYE CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; ADULT; AGED; BIOPSY; BIOSYNTHESIS; COMPARATIVE STUDY; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 33646675355     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000202609.92772.c3     Document Type: Article

References (19)

1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39:429-50.
2. Lee GA, Williams G, Hirst LW, et al. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology 1994;101:360-4.
3. Odrich MG, Jakobiec FA, Lancaster WD, et al. A spectrum of bilateral squamous conjunctival tumors associated with human papillomavirus type 16. Ophthalmology 1991;98:628-35.
4. Lauer SA, Malter JS, Meier R. Human papillomavirus type 18 in conjunctival intraepithelial neoplasia. Am J Ophthalmol 1990;110:23-7.
5. Johnson TE, Tabbara KF, Weatherhead RG, et al. Secondary squamous cell carcinoma of the orbit. Arch Ophthalmol 1997;115:75-8.
6. Tunc M, Char DH, Crawford B, Miller T. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol 1999;83:98-103.
7. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 2002;133:601-6.
8. Yeatts RP, Ford JG, Stanton CA. Topical 5-fluorouracil in treatment of epithelial neoplasia of the conjunctiva and cornea. Ophthalmology 1995;102:1338-44.
9. Liu Z, Carvajal M, Carothers-Carraway CA, et al. Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia. Cornea 2001;20:81-5.
10. Shatos MA, Rios JD, Horikawa Y, et al. Isolation and characterization of cultured human conjunctival goblet cells. Invest Ophthalmol Vis Sci 2003;44:2477-86.
11. Putti TC, To KF, Hsu HC, et al. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 2002;41:144-51.
12. Ford AC, Grandis JR. Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 2003;25:67-73.
13. Dancey J. Epidermal growth factor receptor inhibitors in clinical development. Int J Radiat Oncol Biol Phys 2004;58:1003-7.
14. Pomerantz RG, Grandis JR. The role of epidermal growth factor receptor in head and neck squamous cell carcinoma. Curr Oncol Rep 2003;5:140-6.
15. Grandis JR, Melhem MF, Gooding WE, et al. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-32.
16. Kodama T, Hayasaka S, Setogawa T. Immunohistochemical localization of epidermal growth factor receptor and epithelial antigen in tumors of the human conjunctiva, eyelid, lacrimal gland, and orbit. Graefes Arch Clin Exp Ophthalmol 1995;233:672-6.
17. Aoki S, Kubo E, Nakamura S, et al. Possible prognostic markers in conjunctival dysplasia and squamous cell carcinoma. Jpn J Ophthalmol 1998;42:256-61.
18. Barnes CJ, Bagheri-Yarmand R, Mandal M, et al. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa). Mol Cancer Ther 2003;2:345-51.
19. Yang Z, Bagheri-Yarmand R, Wang RA, et al. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells. Clin Cancer Res 2004;10:658-67.